Literature DB >> 27696297

How the reference values for serum parathyroid hormone concentration are (or should be) established?

J-C Souberbielle1,2, F Brazier3,4, M-L Piketty3,4, C Cormier5, S Minisola6, E Cavalier7.   

Abstract

Well-validated reference values are necessary for a correct interpretation of a serum PTH concentration. Establishing PTH reference values needs recruiting a large reference population. Exclusion criteria for this population can be defined as any situation possibly inducing an increase or a decrease in PTH concentration. As recommended in the recent guidelines on the diagnosis and management of asymptomatic primary hyperparathyroidism, PTH reference values should be established in vitamin D-replete subjects with a normal renal function with possible stratification according to various factors such as age, gender, menopausal status, body mass index, and race. A consensus about analytical/pre-analytical aspects of PTH measurement is also needed with special emphasis on the nature of the sample (plasma or serum), the time and the fasting/non-fasting status of the blood sample. Our opinion is that blood sample for PTH measurement should be obtained in the morning after an overnight fast. Furthermore, despite longer stability of the PTH molecule in EDTA plasma, we prefer serum as it allows to measure calcium, a prerequisite for a correct interpretation of a PTH concentration, on the same sample. Once a consensus is reached, we believe an important international multicentre work should be performed to recruit a very extensive reference population of apparently healthy vitamin D-replete subjects with a normal renal function in order to establish the PTH normative data. Due to the huge inter-method variability in PTH measurement, a sufficient quantity of blood sample should be obtained to allow measurement with as many PTH kits as possible.

Entities:  

Keywords:  Chronic kidney disease; Parathyroid hormone (PTH); Primary hyperparathyroidism; Reference values; Vitamin D

Mesh:

Substances:

Year:  2016        PMID: 27696297     DOI: 10.1007/s40618-016-0553-2

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  52 in total

1.  Effect of outliers and nonhealthy individuals on reference interval estimation.

Authors:  P S Horn; L Feng; Y Li; A J Pesce
Journal:  Clin Chem       Date:  2001-12       Impact factor: 8.327

2.  Interpretation of plasma PTH concentrations according to 25OHD status, gender, age, weight status, and calcium intake: importance of the reference values.

Authors:  Mathilde Touvier; Mélanie Deschasaux; Marion Montourcy; Angela Sutton; Nathalie Charnaux; Emmanuelle Kesse-Guyot; Léopold K Fezeu; Paule Latino-Martel; Nathalie Druesne-Pecollo; Denis Malvy; Pilar Galan; Serge Hercberg; Khaled Ezzedine; Jean-Claude Souberbielle
Journal:  J Clin Endocrinol Metab       Date:  2014-02-14       Impact factor: 5.958

3.  Influence of vitamin D on parathyroid function in the elderly.

Authors:  J M Quesada; W Coopmans; B Ruiz; P Aljama; I Jans; R Bouillon
Journal:  J Clin Endocrinol Metab       Date:  1992-08       Impact factor: 5.958

4.  A novel immunoradiometric assay detects full-length human PTH but not amino-terminally truncated fragments: implications for PTH measurements in renal failure.

Authors:  M R John; W G Goodman; P Gao; T L Cantor; I B Salusky; H Jüppner
Journal:  J Clin Endocrinol Metab       Date:  1999-11       Impact factor: 5.958

5.  Serum osteoprotegerin/osteoclastogenesis-inhibitory factor during pregnancy and lactation and the relationship with calcium-regulating hormones and bone turnover markers.

Authors:  H Uemura; T Yasui; M Kiyokawa; A Kuwahara; H Ikawa; T Matsuzaki; M Maegawa; H Furumoto; M Irahara
Journal:  J Endocrinol       Date:  2002-08       Impact factor: 4.286

6.  Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia.

Authors:  S R Nussbaum; R J Zahradnik; J R Lavigne; G L Brennan; K Nozawa-Ung; L Y Kim; H T Keutmann; C A Wang; J T Potts; G V Segre
Journal:  Clin Chem       Date:  1987-08       Impact factor: 8.327

7.  The effects of pregnancy and lactation on hormonal status and biochemical markers of bone turnover.

Authors:  Csaba More; Harjit P Bhattoa; Peter Bettembuk; Adam Balogh
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2003-02-10       Impact factor: 2.435

8.  Variation in serum and plasma PTH levels in second-generation assays in hemodialysis patients: a cross-sectional study.

Authors:  Dominique Joly; Tilman B Drueke; Corinne Alberti; Pascal Houillier; Ethel Lawson-Body; Kevin J Martin; Catherine Massart; Sharon M Moe; Marie Monge; Jean-Claude Souberbielle
Journal:  Am J Kidney Dis       Date:  2008-04-08       Impact factor: 8.860

9.  IMMULITE 2000 age and sex-specific reference intervals for alpha fetoprotein, homocysteine, insulin, insulin-like growth factor-1, insulin-like growth factor binding protein-3, C-peptide, immunoglobulin E and intact parathyroid hormone.

Authors:  Offie P Soldin; Julia R B Dahlin; Eric G Gresham; Julia King; Steven J Soldin
Journal:  Clin Biochem       Date:  2008-05-15       Impact factor: 3.281

10.  Marked biological variance in endocrine and biochemical markers in childhood: establishment of pediatric reference intervals using healthy community children from the CALIPER cohort.

Authors:  Dana Bailey; David Colantonio; Lianna Kyriakopoulou; Ashley H Cohen; Man Khun Chan; David Armbruster; Khosrow Adeli
Journal:  Clin Chem       Date:  2013-05-01       Impact factor: 8.327

View more
  13 in total

1.  Transoral thyroidectomy: advantages and limitations.

Authors:  G Dionigi; R P Tufano; J Russell; H Y Kim; E Piantanida; A Anuwong
Journal:  J Endocrinol Invest       Date:  2017-04-21       Impact factor: 4.256

2.  Neonatal Severe Hyperparathyroidism: Novel Insights From Calcium, PTH, and the CASR Gene.

Authors:  Stephen J Marx; Ninet Sinaii
Journal:  J Clin Endocrinol Metab       Date:  2020-04-01       Impact factor: 5.958

3.  Correction of vitamin D status by calcidiol: pharmacokinetic profile, safety, and biochemical effects on bone and mineral metabolism of daily and weekly dosage regimens.

Authors:  S Minisola; L Cianferotti; P Biondi; C Cipriani; C Fossi; F Franceschelli; F Giusti; G Leoncini; J Pepe; H A Bischoff-Ferrari; M L Brandi
Journal:  Osteoporos Int       Date:  2017-08-16       Impact factor: 4.507

4.  European Biological Variation Study (EuBIVAS): within- and between-subject biological variation estimates for serum biointact parathyroid hormone based on weekly samplings from 91 healthy participants.

Authors:  Michela Bottani; Giuseppe Banfi; Elena Guerra; Massimo Locatelli; Aasne K Aarsand; Abdurrahman Coşkun; Jorge Díaz-Garzón; Pilar Fernandez-Calle; Sverre Sandberg; Ferruccio Ceriotti; Elisabet González-Lao; Margarita Simon; Anna Carobene
Journal:  Ann Transl Med       Date:  2020-07

5.  The path to the standardization of PTH: Is this a realistic possibility? a position paper of the IFCC C-BM.

Authors:  Etienne Cavalier; Samuel Vasikaran; Harjit P Bhattoa; Annemieke C Heijboer; Konstantinos Makris; Candice Z Ulmer
Journal:  Clin Chim Acta       Date:  2021-01-04       Impact factor: 3.786

6.  Association between Parathyroid Hormone, 25 (OH) Vitamin D, and Chronic Kidney Disease: A Population-Based Study.

Authors:  Wei-Hao Wang; Li-Wei Chen; Chin-Chan Lee; Chiao-Yin Sun; Yu-Chiau Shyu; Heng-Rong Hsu; Rong-Nang Chien; I-Wen Wu
Journal:  Biomed Res Int       Date:  2017-03-07       Impact factor: 3.411

7.  Vitamin D, bone alkaline phosphatase and parathyroid hormone in healthy subjects and haemodialysed patients from West Africa: impact of reference ranges and parathyroid hormone generation assays on the KDIGO guidelines.

Authors:  Etienne Cavalier; Eric Sagou Yayo; Marie-Laure Attoungbre-Hauhouot; Jean-Louis Konan; Carine Yao-Yapo; Dagui Monnet; Appolinaire Gnionsahé; Jean-Claude Souberbielle; Pierre Delanaye
Journal:  Clin Kidney J       Date:  2018-09-05

8.  Parathyroid hormone reference ranges in healthy individuals classified by vitamin D status.

Authors:  N Yalla; G Bobba; G Guo; A Stankiewicz; R Ostlund
Journal:  J Endocrinol Invest       Date:  2019-07-04       Impact factor: 4.256

Review 9.  Perspective and priorities for improvement of parathyroid hormone (PTH) measurement - A view from the IFCC Working Group for PTH.

Authors:  Catharine M Sturgeon; Stuart Sprague; Alison Almond; Etienne Cavalier; William D Fraser; Alicia Algeciras-Schimnich; Ravinder Singh; Jean-Claude Souberbielle; Hubert W Vesper
Journal:  Clin Chim Acta       Date:  2016-10-13       Impact factor: 3.786

Review 10.  Raising awareness on the therapeutic role of cholecalciferol in CKD: a multidisciplinary-based opinion.

Authors:  Sandro Giannini; Sandro Mazzaferro; Salvatore Minisola; Luca De Nicola; Maurizio Rossini; Mario Cozzolino
Journal:  Endocrine       Date:  2017-07-19       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.